A detailed history of Atomi Financial Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 30,673 shares of NVO stock, worth $2.61 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
30,673
Previous 32,876 6.7%
Holding current value
$2.61 Million
Previous $4.69 Billion 22.17%
% of portfolio
0.23%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$119.07 - $145.42 $262,311 - $320,360
-2,203 Reduced 6.7%
30,673 $3.65 Billion
Q2 2024

Jul 26, 2024

BUY
$122.71 - $146.91 $605,819 - $725,294
4,937 Added 17.67%
32,876 $4.69 Billion
Q1 2024

May 07, 2024

BUY
$102.11 - $135.92 $323,688 - $430,866
3,170 Added 12.8%
27,939 $3.59 Billion
Q4 2023

Feb 08, 2024

BUY
$87.78 - $105.45 $1.47 Million - $1.77 Million
16,802 Added 210.89%
24,769 $2.56 Billion
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $724,518 - $1.59 Million
7,967 New
7,967 $725 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Atomi Financial Group, Inc. Portfolio

Follow Atomi Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atomi Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atomi Financial Group, Inc. with notifications on news.